What About Insurance?

More and more genetic tests are being developed to determine people's risk for disease, but as NPR's Michelle Andrews reports at the Shots blog, don't expect insurance companies to pay for all of the tests. Insurers, she says, typically only cover a test if there is strong evidence that there's a health benefit.

"You don't test for testing's sake," Susan Pisano, a spokesperson for the trade group America's Health Insurance Plans, tells Andrews.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.